Cannabis Use in Epilepsy: Parent & Scientist Weighs In. Catherine Jacobson, PhD Director, Clinical Research
|
|
- James Lane
- 6 years ago
- Views:
Transcription
1 Cannabis Use in Epilepsy: Parent & Scientist Weighs In Catherine Jacobson, PhD Director, Clinical Research
2 Professional Background PhD, Neuroscience, Oregon Health & Science University Post-doctoral Fellowship, Basic Science, Epilepsy, Stanford University Published first survey of parental use of cannabis preparations to treat intractable epilepsy (Epilepsy & Behavior, 2013) Post-doctoral Training, Clinical Research, UCSF Pediatric Epilepsy Center Assisted with first compassionate use IND for Epidiolex (2013) Director, Clinical Research, Tilray
3 Early Human Studies 1978 Mechoulam & Carlini 200 mg CBD daily in adult patients with temporal lobe epilepsy 2/4 patients receiving CBD became seizure free 1/4 patients receiving CBD saw a marked reduction in frequency None of the 4 patients receiving placebo reported any change 1980 Cunha et al. 400 mgs CBD daily in adult patients with temporal lobe epilepsy 4/8 patients receiving CBD became seizure free 3/8 patients receiving CBD saw a marked reduction in frequency 1/7 patients in placebo group saw a reduction in frequency 1986 Ames & Cridland 12 patients receiving 200 mg CBD daily saw no benefits
4 Professional Background PhD, Neuroscience, Oregon Health & Science University Post-doctoral Fellowship, Basic Science, Epilepsy, Stanford University Published first survey of parental use of cannabis preparations to treat intractable epilepsy (Epilepsy & Behavior, 2013) Post-doctoral Training, Clinical Research, UCSF Pediatric Epilepsy Center Assisted with first compassionate use IND for Epidiolex (2013) Director, Clinical Research, Tilray
5 Personal Experience with Epilepsy & Cannabis Ben
6 Personal Experience with Epilepsy & Cannabis May 7, 2009 August 18, 2009 Nov & Dec 2009 Ben was born, healthy pregnancy & birth First seizure (keppra, trileptal, phenytoin) High doses of oral steroids present Tegretol, lamictal, depakote, phenobarbital, topamax, onfi, clonazepam, ketogenic diet, VNS Implantation, felbatol, sabril May 2012 First heard about parental treatment with cannabis; tried artisanal preparation (later tested it and found it was sugar water) 2012 & 2013 Separated CBD and THC in my garage; 200mg CBD ~40% reduction in seizure frequency for Ben July 2014 Ben received access to Epidiolex via compassionate use IND; subsequently removed by his physician January 2015 Ben underwent resective brain surgery at Stanford; half of right parietal lobe removed
7 Chemical Structure of Cannabinoids 9 -Tetrahydrocannabinol (THC) Cannabidiol (CBD) Tetrahydrocannabinol (THC) Cannabidiol (CBD)
8 Column Chromatography
9 Personal Experience with Epilepsy & Cannabis May 7, 2009 August 18, 2009 Nov & Dec 2009 Ben was born, healthy pregnancy & birth First seizure (keppra, trileptal, phenytoin) High doses of oral steroids present Tegretol, lamictal, depakote, phenobarbital, topamax, onfi, clonazepam, ketogenic diet, VNS Implantation, felbatol, sabril May 2012 First heard about parental treatment with cannabis; tried artisanal preparation (later tested it and found it was sugar water) 2012 & 2013 Separated CBD and THC in my garage; 200mg CBD ~40% reduction in seizure frequency for Ben July 2014 Ben received access to Epidiolex via compassionate use IND; subsequently removed by his physician January 2015 Ben underwent resective brain surgery at Stanford; half of right parietal lobe removed
10 Issues relevant to the clinical discussion Artisanal cannabis preparations Data for informed treatment Patient-centered care Improving data collection efforts and outcomes
11 Epidiolex vs. Artisanal Cannabis Preparations Epidiolex = Pharmaceutical Preparation One active ingredient: Cannabidiol Manufactured in accordance with ICH guidelines - Stability - Analytical validation - Impurities - Good manufacturing practices Allows for precise dosing Artisanal Preparations Whole plant extracts contain dozens of compounds (cannabinoids & terpenes) Very little to no regulatory oversight in manufacturing standards - Dependent on state regulations of medical cannabis Precise dosing unlikely
12 Importance of Regulating Products Vandrey et al. JAMA 2016 The Globe and Mail Report products tested 83% were inaccurately labeled for THC content 44 products had detectable levels of CBD 13 of these products were labeled for CBD content 9 unregulated dispensary products tested Products were contaminated: 1 yeast & mold 2 microorganism count exceeded limits 3 potentially harmful bacteria 100% were inaccurately labeled for CBD content
13 Cannabis Preparations *Strain names do NOT equal different species *Chemical composition of strains are not the same from seller to seller
14 Cannabis Preparations Chemical composition of the extract or oil depends on: 1. Species of starting raw plant material 2. Extraction methodology a. Solvents b. Heat settings c. Vacuum pressure settings d. Time of extraction
15 Issues relevant to the clinical discussion Artisanal cannabis preparations Data for informed treatment Patient-centered care Improving data collection efforts and outcomes
16 Data for informed treatment Data to inform treatment does NOT equal trials required for FDA approval
17 Data for informed treatment Data to inform treatment does NOT equal trials required for FDA approval Epidiolex provided to 100s of children via compassionate use INDs information gathered: starting dose titration schedule response signal side effects drug-drug interactions adverse events
18 What we don t know What we do know Safe & efficacious dosing of artisanal preparations
19 What we don t know What we do know Safe & efficacious dosing of artisanal preparations Which pediatric syndromes are most likely to respond to artisanal preparations
20 What we don t know What we do know Safe & efficacious dosing of artisanal preparations Which pediatric syndromes are most likely to respond to artisanal preparations Efficacy data (responder rates; seizure frequency reduction vs. placebo)
21 What we don t know What we do know Safe & efficacious dosing of artisanal preparations Which pediatric syndromes are most likely to respond to artisanal preparations Efficacy data (responder rates; seizure frequency reduction vs. placebo) Risks of adverse events of THC in a seizure-prone brain
22 What we don t know What we do know Safe & efficacious dosing of artisanal preparations Which pediatric syndromes are most likely to respond to artisanal preparations Efficacy data (responder rates; seizure frequency reduction vs. placebo) Risks of adverse events of THC in a seizure-prone brain Long-term cognitive side effects of CBD & THC use in a developing brain
23 What we don t know Safe & efficacious dosing of artisanal preparations What we do know Safe & efficacious CBD Dosing: 5-25mg/kg Which pediatric syndromes are most likely to respond to artisanal preparations Efficacy data (responder rates; seizure frequency reduction vs. placebo) Risks of adverse events of THC in a seizure-prone brain Long-term cognitive side effects of CBD & THC use in a developing brain
24 What we don t know Safe & efficacious dosing of artisanal preparations Which pediatric syndromes are most likely to respond to artisanal preparations What we do know Safe & efficacious CBD Dosing: 5-25mg/kg Efficacy of CBD in two specific pediatric epilepsy syndromes Efficacy data (responder rates; seizure frequency reduction vs. placebo) Risks of adverse events of THC in a seizure-prone brain Long-term cognitive side effects of CBD & THC use in a developing brain
25 What we don t know Safe & efficacious dosing of artisanal preparations Which pediatric syndromes are most likely to respond to artisanal preparations Efficacy data (responder rates; seizure frequency reduction vs. placebo) What we do know Safe & efficacious CBD Dosing: 5-25mg/kg Efficacy of CBD in two specific pediatric epilepsy syndromes Side effects of CBD in healthy adults and pediatric patient population Risks of adverse events of THC in a seizure-prone brain Long-term cognitive side effects of CBD & THC use in a developing brain
26 What we don t know Safe & efficacious dosing of artisanal preparations Which pediatric syndromes are most likely to respond to artisanal preparations Efficacy data (responder rates; seizure frequency reduction vs. placebo) What we do know Safe & efficacious CBD Dosing: 5-25mg/kg Efficacy of CBD in two specific pediatric epilepsy syndromes Side effects of CBD in healthy adults and pediatric patient population Risks of adverse events of THC in a seizure-prone brain Side effects of THC in healthy adults and adult patient population Long-term cognitive side effects of CBD & THC use in a developing brain
27 What we don t know Safe & efficacious dosing of artisanal preparations Which pediatric syndromes are most likely to respond to artisanal preparations Efficacy data (responder rates; seizure frequency reduction vs. placebo) What we do know Safe & efficacious CBD Dosing: 5-25mg/kg Efficacy of CBD in two specific pediatric epilepsy syndromes Side effects of CBD in healthy adults and pediatric patient population Risks of adverse events of THC in a seizure-prone brain Side effects of THC in healthy adults and adult patient population Long-term cognitive side effects of CBD & THC use in a developing brain Artisanal CBD preparations contain THC: 100mg dose of CBD also contains 3-5mg THC
28 What we don t know Safe & efficacious dosing of artisanal preparations Which pediatric syndromes are most likely to respond to artisanal preparations Efficacy data (responder rates; seizure frequency reduction vs. placebo) What we do know Safe & efficacious CBD Dosing: 5-25mg/kg Efficacy of CBD in two specific pediatric epilepsy syndromes Side effects of CBD in healthy adults and pediatric patient population Risks of adverse events of THC in a seizure-prone brain Side effects of THC in healthy adults and adult patient population Long-term cognitive side effects of CBD & THC use in a developing brain Artisanal CBD preparations contain THC: 100mg dose of CBD also contains 3-5mg THC Preclinical evidence supports anticonvulsant properties of THC
29 What we don t know Safe & efficacious dosing of artisanal preparations Which pediatric syndromes are most likely to respond to artisanal preparations Efficacy data (responder rates; seizure frequency reduction vs. placebo) What we do know Safe & efficacious CBD Dosing: 5-25mg/kg Efficacy of CBD in two specific pediatric epilepsy syndromes Side effects of CBD in healthy adults and pediatric patient population Risks of adverse events of THC in a seizure-prone brain Side effects of THC in healthy adults and adult patient population Long-term cognitive side effects of CBD & THC use in a developing brain Artisanal CBD preparations contain THC: 100mg dose of CBD also contains 3-5mg THC Preclinical evidence supports anticonvulsant properties of THC Epidemiological studies cannabis use results in fewer hospital admissions of patients
30 What we don t know Safe & efficacious dosing of artisanal preparations Which pediatric syndromes are most likely to respond to artisanal preparations Efficacy data (responder rates; seizure frequency reduction vs. placebo) What we do know Safe & efficacious CBD Dosing: 5-25mg/kg Efficacy of CBD in two specific pediatric epilepsy syndromes Side effects of CBD in healthy adults and pediatric patient population Risks of adverse events of THC in a seizure-prone brain Side effects of THC in healthy adults and adult patient population Long-term cognitive side effects of CBD & THC use in a developing brain Artisanal CBD preparations contain THC: 100mg dose of CBD also contains 3-5mg THC Preclinical evidence supports anticonvulsant properties of THC Epidemiological studies cannabis use results in fewer hospital admissions of patients Uncontrolled seizures very poor outcome
31 Issues relevant to the clinical discussion Artisanal cannabis preparations Data for informed treatment Patient-centered care Improving data collection efforts and outcomes
32 When you treat the patient, you treat the family
33 Patient-centered Care Goal: Provide Best Possible Care to Each Patient Each patient is an individual case Relevance of 50% responder rate or seizure frequency reduction in a given patient population Quality of life improvement cannot be overestimated Seizure frequency Seizure severity Cognitive improvements Behavioral improvements Sleep quality Patient/caregiver empowerment What is the role of the physician in treating the patient?
34 Issues relevant to the clinical discussion Artisanal cannabis preparations Data for informed treatment Patient-centered care Improving data collection efforts and outcomes
35 Improving Data Collection & Outcomes Elephant in the room: How will we, as a community, collect data to inform treatment and thereby increase the chances of better outcomes? Push for legislation that regulates the manufacturing of artisanal cannabis products Hold manufacturers accountable for their manufacturing practices and their products Company-sponsored clinical trials are very unlikely; therefore, NINDS, patient advocacy groups, physicians must collaborate on data collection efforts
36 Thank You Catherine Jacobson, PhD Director, Clinical Research
Changing the Drug Enforcement Administration (DEA) Schedule of Tetrahydrocannabinol (THC), Cannabidiol and Combinations to Promote Research
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 TITLE: Changing the Drug Enforcement Administration (DEA) Schedule of Tetrahydrocannabinol
More informationCannabis for Drug Resistant Epilepsy
Cannabis for Drug Resistant Epilepsy MILA SORIN, MD PEDIATRIC NEUROLOGY APRIL 20, 2018 Introduction -Although more than 20 prescription anti-epileptic drugs (AEDs) are available, they prove to be ineffective
More informationGeorgia Cannabidiol Study Frequently Asked Questions
Georgia Cannabidiol Study Frequently Asked Questions 1. Why was the Georgia Cannabidiol Study initiated? In January 2014, Representative Allen Peake visited with Haleigh Cox, a 4-year-old girl with severe
More informationCannabis in the treatment of Autism:
Cannabis in the treatment of Autism: Are we ready? Deb Karhson, PhD and Lawrence Fung, MD, PhD Cannabis Anecdotal Data: Comparing Epilepsy and Autism+ Science of Cannabinoids: Endocannabinoid System Receptor
More informationPrescribing and Monitoring Anti-Epileptic Drugs
Prescribing and Monitoring Anti-Epileptic Drugs Mark Granner, MD Clinical Professor and Vice Chair for Clinical Programs Director, Iowa Comprehensive Epilepsy Program Department of Neurology University
More informationSelf Report Seizure Survey Summary 2017
Self Report Seizure Survey Summary 2017 Tetrasomy 18p 61 responses 33 had at least one seizure = 54% 8 had a seizure in the last year Valproate (Depakote) 7 Valproate (Depakote, Epilium) 2 Lamotrigene
More informationDr. Hagit Marchaim, Regulatory Affairs & Drug Development Consulting - HMC
Dr. Hagit Marchaim, Regulatory Affairs & Drug Development Consulting - HMC 1 Disclosures I (Dr. Hagit Marchaim) have no financial relationships to disclose concerning the content of this presentation or
More informationMedical Cannabis MATT WEBSTER DO, MS
Medical Cannabis MATT WEBSTER DO, MS Cannabis Sativa One of the oldest used drugs and medicinal remedies Most commonly abused illicit drug in the US There has been increasing access for medicinal MJ use
More information[ APPLICATION NOTE ] The Separation of 8 -THC, 9 -THC, and Their Enantiomers by UPC 2 Using Trefoil Chiral Columns INTRODUCTION APPLICATION BENEFITS
The Separation of 8 -THC, 9 -THC, and Their Enantiomers by UPC 2 Using Trefoil Chiral Columns Jacquelyn Runco, Andrew Aubin, and Catharine Layton Waters Corporation, Milford, MA, USA APPLICATION BENEFITS
More informationCBD OIL BUYER S GUIDE
CBD OIL BUYER S GUIDE CBD OIL CBD (cannabidiol) oil has become incredibly popular for pets and with good reason. Dog owners are finding it helps their dogs with a number of different health issues. It
More informationThe products being taken by children with epilepsy are not the equivalent of the marijuana widely used for recreational purposes.
Epilepsy Foundation of Colorado The Use of Cannabis to Treat Children with Epilepsy Updated February 2016 The use of extracts from marijuana plants (cannabis) to treat children with epilepsy has been in
More informationMarijuana as Medicine
Marijuana as Medicine What is medical marijuana? The term medical marijuana refers to using the whole, unprocessed marijuana plant or its basic extracts to treat symptoms of illness and other conditions.
More information11/7/2018 EPILEPSY UPDATE. Dr.Ram Sankaraneni. Disclosures. Speaker bureau LivaNova
EPILEPSY UPDATE Dr.Ram Sankaraneni Disclosures Speaker bureau LivaNova 1 Outline New onset Seizure Investigations in patients with epilepsy Medical management of epilepsy Non Pharmacological options in
More informationGeneric Name (Brand Name) Available Strengths Formulary Limits. Primidone (Mysoline) 50mg, 250mg -- $
MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Epilepsy P&T DATE: 2/15/2017 THERAPEUTIC CLASS: Neurologic Disorders REVIEW HISTORY: 2/16 LOB AFFECTED: Medi-Cal (MONTH/YEAR)
More informationMedical Marijuana: The Move to Schedule II
Medical Marijuana: The Move to Schedule II David Deitz, MD, PhD David Deitz & Associates Today s discussion Does medical marijuana actually treat anything? What are the workplace issues? What are the interactions
More informationMedicinal cannabis. What is medicinal cannabis? What are cannabinoids? The endocannabinoid system
Medicinal cannabis What is medicinal cannabis? Broadly speaking, medicinal cannabis is cannabis prescribed to relieve the symptoms of a medical condition, such as epilepsy. It is important to make the
More informationA GUIDE TO TALKING WITH YOUR DOCTOR ABOUT EPIDIOLEX
A GUIDE TO TALKING WITH YOUR DOCTOR ABOUT EPIDIOLEX You are encouraged to have an open conversation with your doctor about your treatment goals and current medicines. It is important in determining if
More informationMinnesota Medical Cannabis Program. October 24, 2017
Minnesota Medical Cannabis Program October 24, 2017 Agenda: Overview of Minnesota Medical Cannabis Program Conditions, roles, products Laboratory Issues Program Evaluation * indicates a hyper-link to website
More informationThe Company. Beyond Pioneering
The Company Beyond Pioneering Standardisation Bedrocan is the world s most experienced producer of legal medicinal cannabis. We are currently the only company producing medicinal cannabis flos to good
More informationAntiepileptics. Medications Comment Quantity Limit Carbamazepine. May be subject Preferred to quantity limit Epitol
Market DC Antiepileptics Override(s) Approval Duration Prior Authorization 1 year Step Therapy Quantity Limit *Indiana Medicaid See State Specific Mandate below *Maryland Medicaid See State Specific Mandate
More information9/13/2017. Marijuana and the Brain Matthew Wong, MD Assistant Professor, Department of Neurology, Epilepsy Section. Disclosures.
Marijuana and the Brain Matthew Wong, MD Assistant Professor, Department of Neurology, Epilepsy Section Disclosures Site principal investigator of studies of cannabidiol(epidiolex) in the treatment of
More informationKansas Sheriffs Association PO Box 1122 Pittsburg, KS (620)
Kansas Association of Chiefs of Police PO Box 780603 Wichita, KS 67278 (316)733-7301 Kansas Sheriffs Association PO Box 1122 Pittsburg, KS 66762 (620)230-0864 Kansas Peace Officers Association PO Box 2592
More informationPoisons Amendment (2018 Measures No. 1) Instrument 2018
Poisons Amendment (2018 Measures No. 1) Instrument 2018 I, {insert author} make the following instrument. Dated 1 st April 2018 {insert author} Poisons Amendment (2018 Measures No. 1) Instrument 2018 Page
More informationDoes Legality equal Legitimacy? The challenges of fostering safe practice with state legalization of marijuana
Does Legality equal Legitimacy? The challenges of fostering safe practice with state legalization of marijuana Carla Lomuscio, LCSW, Betsy Long, MSW and Amy Carver, PharmD Disclosures We have no financial
More informationGuidance on the use of cannabis based products for medicinal use in children and young people with epilepsy
Guidance on the use of cannabis based products for medicinal use in children and young people with epilepsy 31 October 2018 Contents Glossary... 3 1 Introduction... 4 2 Background... 5 3 Summary of current
More informationNew Patient Questionnaire - Epilepsy
New Patient Questionnaire - Epilepsy Person completing this form: (if other than the patient) GENERAL SEIZURE HISTORY Relationship: When do you think your child had their first seizure? When was the last
More informationDear Colleague SUPPLEMENTARY INFORMATION ON CANNABIS BASED PRODUCTS FOR MEDICINAL USE
Directorate of Chief Medical Officer T: 0131-244 2470 E: John.Hannah@gov.scot Dear Colleague SUPPLEMENTARY INFORMATION ON CANNABIS BASED PRODUCTS FOR MEDICINAL USE Following my letter of 31 October 2018
More informationGW Pharmaceuticals plc. Investor Presentation August 2014
GW Pharmaceuticals plc Investor Presentation August 2014 Forward Looking Statements and Disclaimer This presentation contains forward-looking statements. Some of the matters discussed concerning our operations
More informationThe Shifting Federal Regulation of Cannabis Products
The Durham Bar 2019 CLE Program The Shifting Federal Regulation of Cannabis Products Erica M. Jackson, FDA Partner K&L Gates February 6, 2019 Copyright 2018 by K&L Gates LLP. All rights reserved. OVERVIEW
More informationI am pleased to highlight for this Honourable House and the public. that today the Government will be laying amendments to the
MINISTERIAL STATEMENT TO THE HOUSE OF ASSEMBLY BY THE HONOURABLE KIM N. WILSON, JP, MP MINISTER OF HEALTH UPDATES AND MODERNIZATION OF DRUG SCHEDULES 24 November 2017 Mr Speaker and Honourable Members,
More informationQuality Assessments for an Organically-Complex Drug - Part 1 Background and the Chemometrics Role
Quality Assessments for an Organically-Complex Drug - Part 1 Background and the Chemometrics Role Dr Peter Gibson Technical Director Sovereign House, Vision Park, Histon, Cambridge, CB24 9BZ Global leaders
More informationCoalition for Medical Marijuana Research & Education
Coalition for Medical Marijuana Research & Education Nagi Kumar, Ph.D., R.D., FADA Professor, Oncologic Sciences Director, Cancer Chemoprevention Executive Director, Coalition for Medical Marijuana Research
More informationResearch and Advances in Epilepsy. Preeti Puntambekar, MD, PHD Epileptologist Northeast regional epilepsy group
Research and Advances in Epilepsy Preeti Puntambekar, MD, PHD Epileptologist Northeast regional epilepsy group Epilepsy History Hippocrateson the sacred disease Galen Avicenna Middle ages Renaissance Paracelcus
More informationSeizures (epilepsy) and brain tumours - treatment
Seizures (epilepsy) and brain tumours - treatment Seizures are the most common first (onset) symptom that leads to a brain tumour diagnosis in adults. Many people with brain tumours develop seizures later
More informationPOLICY NUMBER: POL 153
Chapter: CLAIMS Subject: MEDICAL CANNABIS Effective Date: October 25, 2018 Last Update: October 25, 2018 PURPOSE STATEMENT The purpose of this policy is to explain how the Workers Compensation Board determines
More informationCDHA 2016 Fall Symposium. Speaker Handout Files. For registered attendees only
CDHA 2016 Fall Symposium Speaker Handout Files For registered attendees only Providing Care in a Marijuana Legal World Heather Rogers, BSDH heatherrdh@heatherrdh.com Objectives We will discuss some of
More informationSUPER SNOUTS CBD150 & CBD300 OIL FOR DOGS & CATS
SUPER SNOUTS CBD150 & CBD300 OIL FOR DOGS & CATS Why choose Super Snouts CBD Oils? Super Snouts has an outstanding reputation for creating well researched, effective and affordable health supplements for
More informationEpilepsy 101. Overview of Treatment Kathryn A. O Hara RN. American Epilepsy Society
Epilepsy 101 Overview of Treatment Kathryn A. O Hara RN American Epilepsy Society Objectives Describe the main treatment options for epilepsy Identify factors essential in the selection of appropriate
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Diacomit) Reference Number: CP.PMN.184 Effective Date: 09.25.18 Last Review Date: 11.18 Line of Business: Commercial, Medicaid Revision Log See Important Reminder at the end of this policy
More informationHistory of Medical Cannabis in Nursing
History of Medical Cannabis in Nursing Kristen Luttenberger RN, MSN, CCRN, APNc http://marijuanapolitics.com/wp-content/uploads/2016/07/caduceus-lg.jpg https://images-na.ssl-imagesamazon.com/images/i/41gtt5pb4el._sx314_bo1,204,203,200_.jpg
More informationFrom Opioid Replacement to Managing Chronic Pain: What is CBD?
From Opioid Replacement to Managing Chronic Pain: What is CBD? Kalev Freeman, MD PhD Assistant Professor of Surgery and Pharmacology, University of Vermont Laura Mann Integrative Healthcare Lecture Series
More informationCannabidiol, or CBD, Benefits for Pain, Mental Illness & Anxiety
Cannabidiol, or CBD, Benefits for Pain, Mental Illness & Anxiety The use of medical marijuana continues to be an emotionally and politically charged issue. Although cannabis oil preparations have been
More informationFederal Law: Marijuana
Federal Law: Marijuana Marijuana is a Schedule I drug under Federal Controlled Substances Act Makes possession, usage, purchase, sale, and/or cultivation of marijuana illegal at the federal level May not
More informationCBD Oil: Anxiety Aid & Much More
CBD Oil: Anxiety Aid & Much More This often misunderstood hemp extract may be a health miracle for many. LISA TURNER NOV 1, 2017 betternutrition.com You ve probably heard of and wondered about CBD (cannabidiol),
More informationMULTIPLE SCLEROSIS & OTHER NEUROLOGICAL DISEASES
How Nutrition Changes the Aging Brain MULTIPLE SCLEROSIS & OTHER NEUROLOGICAL DISEASES Nafisa Jadavji, PhD nafisa.jadavji@carleton.ca Outline for Lecture Topics from Lecture #5 Multiple Sclerosis Parkinson
More informationJuly 15 TH, ANDREW MEDVEDOVSKY, M.D. Board Certified Neurologist & Pain Medicine Specialist Director New Jersey Alternative Medicine
MEDICAL CANNABIS FOR NEUROLOGICAL DISEASES July 15 TH, 2017 ANDREW MEDVEDOVSKY, M.D. Board Certified Neurologist & Pain Medicine Specialist Director New Jersey Alternative Medicine GOALS AND OBJECTIVES
More informationCannabidiol as a potential treatment for anxiety disorders. Esther Blessing, MD PhD
Cannabidiol as a potential treatment for anxiety disorders Esther Blessing, MD PhD Overview History and of cannabidiol (CBD) and cannabis Safety and tolerability of CBD CBD pharmacology Clinical need for
More informationClinical Policy: Clobazam (Onfi) Reference Number: CP.PMN.54 Effective Date: Last Review Date: Line of Business: HIM, Medicaid
Clinical Policy: (Onfi) Reference Number: CP.PMN.54 Effective Date: 11.01.12 Last Review Date: 08.18 Line of Business: HIM, Medicaid Revision Log See Important Reminder at the end of this policy for important
More informationQuestions & answers on the use of cannabis sativa L. and cannabinoids (such as cannabidiol) as foodstuffs or within foodstuffs
Questions & answers on the use of cannabis sativa L. and cannabinoids (such as cannabidiol) as foodstuffs or within foodstuffs Table of contents 1. Is there a difference between Cannabis and hemp?... 2
More informationGW Pharmaceuticals Announces New Physician Reports of Epidiolex(R) Treatment Effect in Children and Young Adults With Treatment-Resistant Epilepsy
December 7, 2015 GW Pharmaceuticals Announces New Physician Reports of Epidiolex(R) Treatment Effect in Children and Young Adults With Treatment-Resistant Epilepsy As previously announced, seven posters
More informationWELSH HEALTH CIRCULAR
WHC/2018/039 WELSH HEALTH CIRCULAR Issue Date: 30 October 2018 STATUS: INFORMATION CATEGORY: HEALTH PROFESSIONAL LETTER Title: The rescheduling of Cannabis for medicinal purposes Date of Expiry / Review
More informationWHO WE ARE PROVIDING YOU WITH SUPREME CBD PRODUCTS SINCE 2011.
SUPREME CBD HEALTH AND WELLNESS 2017 WHO WE ARE PROVIDING YOU WITH SUPREME CBD PRODUCTS SINCE 2011. PHARMAHEMP is a pioneering European grower of organic hemp, a trusted producer and supplier of superior
More informationPharmacy Medical Necessity Guidelines: Anticonvulsants/Mood Stabilizers
Pharmacy Medical Necessity Guidelines: Anticonvulsants/Mood Stabilizers Effective: December 18, 2017 Prior Authorization Required Type of Review Care Management Not Covered Type of Review Clinical Review
More informationWHO Expert Committee on Drug Dependence Pre-Review: Extracts and tinctures of cannabis. Expert Peer Review 2
WHO Expert Committee on Drug Dependence Pre-Review: Extracts and tinctures of cannabis Expert Peer Review 2 1. Comments based on the review report a. Evidence on dependence and abuse potential Extracts
More informationCurious about Cannabis? Navigating the cannabis landscape in Pennsylvania LINDSEY MESTON, PHARMD ASHLEY FIRM, PHARMD
Curious about Cannabis? Navigating the cannabis landscape in Pennsylvania LINDSEY MESTON, PHARMD ASHLEY FIRM, PHARMD Speaker Disclosures We have/had no financial relationships with any commercial interests
More informationJames Donaldson CEO and Executive Director
Welcome! James Donaldson CEO and Executive Director Dr. Natasha Ryz Chief Science Officer, Zenabis Cannabis 101 Introduction to Cannabis Plant Cannabis is a genus of flowering plants within the family
More informationObjectives / Learning Targets: The learner who successfully completes this lesson will be able to demonstrate understanding of the following concepts:
Boone County Fire District EMS Education-Paramedic Program EMS 270 Medical Cases-Seizures Resources Seizures screencast Seizures Flowchart and Seizures Flowchart Video Explanation Objectives / Learning
More informationADVANCED CLINICAL CANNABINOID PROVIDER EXAM ACCP
ADVANCED CLINICAL CANNABINOID PROVIDER EXAM ACCP Page 1 1. In what year did the possession and transfer of cannabis for recreational use become illegal in the United States? A. 1937 B. 1941 C. 1933 2.
More informationBotanical Division Update Europe and Australia
3 July 2017 ASX Code: MXC Botanical Division Update Europe and Australia In the Czech Republic, over 470 medicinal cannabis plants have been successfully transferred to the Company s 1,000m 2 outdoor greenhouse
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Absence seizures, 6 in childhood, 95 Adults, seizures and status epilepticus in, management of, 34 35 with first-time seizures. See Seizure(s),
More informationSusan Audino, PhD S.A. Audino & Associates, LLC
Cachexia, Cancer, Chronic Pain, Epilepsy, Glaucoma, HIV, AIDS, Multiple Sclerosis, Nausea, ALS, Crohn s, Hepatitis C, Anorexia, Arthritis, Migraine, Parkinson s, Damage to the Nervous Tissue of the Spinal
More informationCanadian Expert Drug Advisory Committee Final Recommendation Plain Language Version
Canadian Expert Drug Advisory Committee Final Recommendation Plain Language Version LACOSAMIDE (Vimpat UCB Canada Inc.) Indication: Epilepsy, Partial-Onset Seizures Recommendation: The Canadian Expert
More informationConstance Finley Founder and CEO
ORIGIN & MISSION Constance Therapeutics is a vertically integrated medicinal cannabis company that is setting the industry standard for quality, potency and consistency with a new category of wholeplant
More informationA Patient s Guide to Accessing Medical Cannabis in the UK
A Patient s Guide to Accessing Medical Cannabis in the UK Contents... 1 A note from the campaign.....2 A note from Hannah Deacon.....3 Frequently Asked Questions.....4 Glossary... 7 Resource Bank...10
More informationGlobal Legal Cannabis Market: Size, Trends & Forecasts ( ) September 2018
Global Legal Cannabis Market: Size, Trends & Forecasts (2018-2022) September 2018 Global Legal Cannabis Market: Coverage Executive Summary and Scope Introduction/Market Overview Global Market Analysis
More informationCannabis in the Community
Department of Pediatrics Cannabis in the Community The Unintended Consequences of Increased Marijuana Availability on the Pediatric Population Karen Buchi, MD Professor of Pediatrics Chair, University
More informationBeginner s Guide to CBD OIL
Beginner s Guide to CBD OIL What is CBD? In recent years, CBD oil has skyrocketed in popularity, but it also has raised concerns and controversy usually due to a misunderstanding of what CBD is all about.
More informationPharmaceutical Quality Control of Complex Botanicals
Pharmaceutical Quality Control of Complex Botanicals Dr Peter Gibson Technical Director Porton Down Science Park, Salisbury, SP4 0JQ, United Kingdom GW Pharmaceuticals To be the global leader in prescription
More information(B) A testing laboratory shall analyze a sample of at least one half of one percent of the
ACTION: Final DATE: 08/14/2017 9:26 AM 3796:4-2-04 Testing laboratory analysis requirements. (A) A testing laboratory shall analyze a sample of at least one half of one percent of the net weight of the
More informationSOMNUS VITM Supplement for sleep and wellness
SOMNUS VITM Supplement for sleep and wellness Unscheduled and non-psychoactive, CANNABINOL represents a major market opportunity as a sedative as well as a potential treatment for insomnia, anxiety and
More informationNASDAQ: GWPH March, 2019
NASDAQ: GWPH March, 2019 Grace Living with Dravet syndrome, Being treated with Epidiolex 2019 GW Pharmaceuticals. All rights reserved. Forward-Looking Statements This presentation contains forward-looking
More informationCannabis derived terpenes for sale
Cannabis derived terpenes for sale Buy real weed online! Your premium edibles. Cannabis Oil. Canabidol CBD cannabis oil (CBD Oli) is derived from EU approved, UK & US legal, industrial hemp (Cannabis Sativa
More informationPATIENT INTAKE FORM. Name: Address: Town: State: Zip Code: MMJ Card #: Exp. Date: Drivers License #: Exp. Date: Home Phone: Cell:
PATIENT INTAKE FORM Name: Last Name First Name Date of Birth: / / Gender: Male Female Address: Town: State: Zip Code: MMJ Card #: Exp. Date: Drivers License #: Exp. Date: Home Phone: Cell: Email: Primary
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Lacosamide (Vimpat) Reference Number: CP.PMN.155 Effective Date: 10.01.18 Last Review Date: 07.13.18 Line of Business: Oregon Health Plan Revision Log See Important Reminder at the end
More information16 February Cannabis Standards and their relationship to Clinical Health Outcomes
Cannabis Standards and their relationship to Clinical Health Outcomes Andrew Samann CEO and Founder Orion GMP Solutions info@oriongmp.com Follow us on Instagram @orion_gmp 16 February 2018 Cannabis Standards
More informationClinical Policy: Clobazam (Onfi) Reference Number: CP.PMN.54 Effective Date: Last Review Date: Line of Business: HIM, Medicaid
Clinical Policy: (Onfi) Reference Number: CP.PMN.54 Effective Date: 11.01.12 Last Review Date: 11.18 Line of Business: HIM, Medicaid Revision Log See Important Reminder at the end of this policy for important
More informationWeeding out the myths on Medical Cannabis
Weeding out the myths on Medical Cannabis Presented by A/Prof David Allsop Lambert Initiative for Cannabinoid Therapeutics University of Sydney For Walk on the Wild Side 2016: Superstition or Evidence?
More informationI would like to begin by acknowledging that we are on the ancestral grounds of the Beothuk people
I would like to begin by acknowledging that we are on the ancestral grounds of the Beothuk people Introduction to the Cannabinoid System And Medical Use Dr Alia Norman Radiation Oncologist Cannabinoid
More informationA look at Marijuana in 2014
A look at Marijuana in 2014 Paul Snyder MA., LADC Overview and Objectives Discuss the mental and physical effects of marijuana use Describe the criteria for Cannabis use disorder according to the DSM 5
More informationUnderstanding Hemp Extracts and CBD Oil. Quality assurance, product selection, and serving size tracking.
Understanding Hemp Extracts and CBD Oil. Quality assurance, product selection, and serving size tracking. When selecting cannabis products, quality is the highest priority. Regulations in the hemp industry
More informationConflicts of interest
David Casarett MD MA Professor of Medicine Chief of Palliative Care Duke University Conflicts of interest SAB: Curio Wellness, Gram Research, Resolve Digital, Clinicann Senior advisor: Silver Swan Capital
More informationSusan Allen-Evenson Hosts: Laura Lagano, MS, RDN, CDN Prepare for the Next Level: Incorporating Holistic Cannabis in the Nutrition Practice
Susan Allen-Evenson Hosts: Laura Lagano, MS, RDN, CDN Prepare for the Next Level: Incorporating Holistic Cannabis in the Nutrition Practice Integrative Clinical Nutritionist, Laura Lagano MS, RDN, CDN
More informationCannabinoids: access and symptom management in cancer
Cannabinoids: access and symptom management in cancer Appetite stimulation Anecdotal reports suggest marijuana stimulates appetite AIDS/HIV dronabinol 2.5 mg bd v placebo (n=88) increase in appetite 38%
More informationGW Pharmaceuticals plc. Investor Presentation May 2015
GW Pharmaceuticals plc Investor Presentation May 2015 Disclaimers FORWARD-LOOKING STATEMENTS This presentation contains forward-looking statements that are based on our management s beliefs and assumptions
More informationCannabis & Hemp therapeutic solutions
Cannabis & Hemp therapeutic solutions with Our Cannabis & Hemp quality standards Thanks to their rich characterization and proprietary extraction method, our therapeutic solutions are a reference point
More informationLegalizing Industrial Hemp in the States. NCSL Agricultural Task Force Meeting December 9, 2014 Presented by: Eric Steenstra President, Vote Hemp
Legalizing Industrial Hemp in the States NCSL Agricultural Task Force Meeting December 9, 2014 Presented by: Eric Steenstra President, Vote Hemp What is Industrial Hemp? Industrial hemp is the non-psychoactive,
More informationMarijuana Enforcement Division Consumer Safety Presentation. Kyle Lambert Deputy Director Analysis & Planning Section
Marijuana Enforcement Division Consumer Safety Presentation Kyle Lambert Deputy Director Analysis & Planning Section Kyle.Lambert@state.co.us Colorado Licensed Commercial Market Two Industry Segments Medical
More informationWhat s Hot. Thermal Ablation. Slide 1. Slide 2. Slide 3
Slide 1 Hot Topics in the World of Epilepsy Joseph I. Sirven, MD Professor and Chairman Department of Neurology 1 Slide 2 Surgery & Devices for Epilepsy Seizure Emergencies Cannabis What s Hot Slide 3
More information4/15/2019. US States with Marijuana Laws in Have ACOG and SMFM taken notice? THE EFFECTS OF MARIJUANA USE ON PREGNANCY AND LACTATION
THE EFFECTS OF MARIJUANA USE ON PREGNANCY AND LACTATION Susan R Davidson, MD Maternal Fetal Medicine Department of Ob/Gyn St. Mary s Hospital Madison, WI SSM Health I HAVE NO FINANCIAL DISCLOSURES TO REPORT
More informationCannabis and cannabinoids for medicinal purposes
Cannabis and cannabinoids for medicinal purposes International Evidence and Evidence for Practice in Australia Michael Farrell Louisa Degenhardt, Wayne Hall, Nicholas Buckley, Megan Weir, Suzi Neilsen,
More informationA Primer About Cannabidiol And The Benefits of CBD
A Primer About Cannabidiol And The Benefits of CBD Scientists are rapidly discovering more and more about the rather amazing abilities of the cannabinoids found in the cannabis plant. Most of them have
More informationQuick Read Series. Information for people with seizure disorders
Quick Read Series Information for people with seizure disorders 2003 Epilepsy Foundation of America, Inc. This pamphlet is designed to provide general information about epilepsy to the public. It does
More informationTitle: CBD-enriched medical cannabis for intractable pediatric epilepsy. The current Israeli experience
Title: CBD-enriched medical cannabis for intractable pediatric epilepsy. The current Israeli experience Author: Michal Tzadok Shimrit Uliel-Siboni Ilan Linder Uri Kramer Orna Epstein Shai Menascu Andrea
More informationResearch on Cannabis and PD: Is there any evidence?
Research on Cannabis and PD: Is there any evidence? Benzi M. Kluger, MD, MS Associate Professor of Neurology and Psychiatry Director Movement Disorders Center University of Colorado Denver DISCLOSURES
More informationFor personal use only
28 May 2015 PYL AND MMJ ON TRACK FOR REVENUES IN JULY Highlights: Production of MMJ s GMP-produced CBD food supplement capsules commenced 25 May 2015 Capsules to be branded and sold as Sativol TM Sativol
More informationMinnesota Medical Cannabis Program: Patient Experiences from the First Program Year Executive Summary
Minnesota Medical Cannabis Program: Patient Experiences from the First Program Year Executive Summary EXECUTIVE SUMMARY EARLY RELEASE COMPLETE REPORT RELEASE EXPECTED JUNE 2017 May 11, 2017 111n Minnesota
More informationCANNABIS FOR THE RHEUMATOLOGIST
CANNABIS FOR THE RHEUMATOLOGIST Dr Jagtar Singh Nijjar NIHR Clinical Lecturer in Rheumatology Disclosures None 1 Overview The history of cannabis use Anecdotal use of cannabis in chronic pain The biology
More informationDenver s Regulation of Hemp Products
Denver s Regulation of Hemp Products Denver s Nationally Accredited Public Health Department Kara Lavaux 5/9/18 Rocky Mountain Food Safety Conference CONNECT WITH US 311 POCKETGOV DENVERGOV.ORG DENVER
More informationMarijuana and Health
Marijuana and Health MNCAMH June Webinar June 9, 2017 Ken Winters, Ph.D. Adjunct Faculty, Dept. of Psychology University of Minnesota & Senior Scientist, Oregon Research Institute winte001@umn.edu Web-Based
More information